Background: Benign neural tumors, including schwannomas, neurofibromas, and meningiomas, are non-malignant growths originating from nerve tissues. Despite their benign nature, these tumors can cause significant morbidity due to their location and potential for recurrence, posing challenges in clinical management. Understanding the clinico-pathologic characteristics of these tumors is essential to optimize treatment strategies and improve patient outcomes. Aim: This study aims to analyze the clinical presentations, histopathological features, and surgical outcomes of benign neural tumors, focusing on factors influencing recurrence and complications. Methods: A descriptive observational study was conducted. A total of 57 participants diagnosed with benign neural tumors were included based on specific inclusion criteria. Data on demographics, tumor characteristics, clinical presentations, histopathological findings, and surgical outcomes were collected and analyzed using SPSS version 23.0. Statistical tests included descriptive analysis, Chi-square, and t-tests, with a p-value <0.05 considered significant. Results: The study population consisted of 29 males and 28 females, with a mean age of 42.5 years. Schwannomas were the most common tumor type (56.1%), followed by neurofibromas (31.6%) and meningiomas (12.3%). Localized pain (66.7%) and neurological deficits (45.6%) were the predominant clinical symptoms. Complete resection was achieved in 86% of cases, with a recurrence rate of 5.3%, mainly seen in neurofibromas. The overall complication rate was 10.5%, including cerebrospinal fluid leakage and wound infections. A statistically significant correlation (p=0.023) was observed between neurofibromas and higher recurrence rates. Conclusion: Benign neural tumors present diverse clinical challenges due to their location and histopathological variations. Surgical resection is effective, with low recurrence and complication rates, though neurofibromas exhibit a higher tendency for recurrence. Accurate diagnosis, tailored surgical planning, and vigilant postoperative monitoring are crucial for optimizing outcomes. Recommendations: Future studies should focus on exploring adjunctive therapies, particularly for neurofibromas, to reduce recurrence rates. Additionally, incorporating genetic and molecular profiling could further enhance personalized treatment approaches for patients with benign neural tumors. Keywords: Benign neural tumors, schwannoma, neurofibroma, recurrence, clinico-pathologic analysis